Nanobiotix Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Nanobiotix stock has a consensus rating of "Buy" and an average price target of $42.98. The average 1-year stock price forecast is 20.29% higher than the current stock price, while the lowest is $29.77 (-16.68%) and the highest is $70.3 (+96.75%).

Price Target: $42.98 (+20.29%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$29.77	$42.98	$37.82	$70.3
Change	-16.68%	+20.29%	+5.85%	+96.75%

Analyst Ratings

The average analyst rating for Nanobiotix stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	5	6	6	5	5	5
Buy	0	0	0	1	0	0
Hold	0	0	0	0	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	6	6	6	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Dai UBS	UBS	Hold Maintains $30	Hold	Maintains	$30	-16.04%	Jun 4, 2026
Michael Schmidt Guggenheim	Guggenheim	Buy Reiterates $36	Buy	Reiterates	$36	+0.76%	May 5, 2026
Tara Bancroft TD Cowen	TD Cowen	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Apr 1, 2026
Jonathan Chang Leerink Partners	Leerink Partners	Buy Maintains $26 → $37	Buy	Maintains	$26 → $37	+3.55%	Apr 1, 2026

Financial Forecast

Revenue This Year

43.85M

from 32.59M

34.55%

from 32.59M

Revenue Next Year

54.52M

from 43.85M

24.33%

from 43.85M

EPS This Year

-0.30

from -0.50

EPS Next Year

-0.24

from -0.30

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	2.65M	4.78M	36.21M	-7.19M	32.59M	43.85M
Revenue Growth	13.85%	80.43%	658.10%	-	-	34.55%
Gross Profit	2.65M	4.78M	36.21M	-7.19M	32.59M	39.91M
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	91.00%
Operating Income	-47.17M	-45.72M	-24.24M	-68.26M	-10.88M	-10.80M
Net Income	-47.00M	-57.04M	-39.70M	-68.13M	-23.96M	-10.42M
EPS	-	-	-	-	-0.50	-0.30
Free Cash Flow	-13.94M	-24.74M	-5.35M	-33.16M	-7.89M	-30.05M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue	2026	2027	2028
High	78.6M
Avg	43.9M
Low	10.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	141.2%
Avg	34.5%
Low	-69.3%

EPS Forecast

EPS	2026	2027	2028
High	0.32
Avg	-0.30
Low	-0.91

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-